²é¿´: 1380  |  »Ø¸´: 10

gdqabc

Òø³æ (³õÈëÎÄ̳)

[½»Á÷] ¡¾ÇóÖú¡¿¹ØÓÚ»¯Ñ§Ãû³ÆpnuÀ໯ºÏÎïµÄÇóÖú ÒÑÓÐ4È˲ÎÓë

±ÈÈ绯ѧÃû³Æpnu109112´ú±íÒ»ÌØ¶¨½á¹¹µÄ»¯ºÏÎÆäÖÐpnuÊÇʲôÒâ˼£¿Ôõô¾Ý´Ë²éÕÒÆä½á¹¹Ê½£¿¶àл
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

solomoe

Í­³æ (³õÈëÎÄ̳)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
gdqabc(½ð±Ò+1): 2010-10-24 08:50:46
Õâ¸ö»¹ÕæÊDz»ÖªµÀÀ´
רҵ¹úÍâ¶ÔÕÕÆ·²É¹º£¬ÈçÓÐÒâÏòÇëµÇ¼http://www.unitedyuyu.com/doc/pro0.htm»òÕßÖ±½ÓµçÓÊÁªÏµunitedyuyu@foxmail.com£¬µç»°0755-82282037ÉîÛÚÊÐÁªºÏÓÅÓÑ...
2Â¥2010-10-14 13:37:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

qwk123

½û³æ (ÕýʽдÊÖ)

gdqabc(½ð±Ò+1):»¶Ó­ÌÖÂÛ 2010-10-24 08:51:15
±¾ÌûÄÚÈݱ»ÆÁ±Î

3Â¥2010-10-15 11:05:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gdqabc

Òø³æ (³õÈëÎÄ̳)

ºÇºÇ£¬Êǰ¡£¬Ï£ÍûÄܵõ½¸÷λ´óϺµÄÖ¸½Ì
4Â¥2010-10-15 15:23:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nkbeholder

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
gdqabc(½ð±Ò+1):»¶Ó­ÌÖÂÛ 2010-10-24 08:51:28
ÊÇ´úºÅ°É¡£
5Â¥2010-10-15 15:55:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

solomoe

Í­³æ (³õÈëÎÄ̳)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
koria0727:Çë²»ÒªÖØ¸´»ØÌû¡£ 2010-10-15 17:09:24
koria0727:Ç©ÃûΪ³àÂãÂãµÄ¹ã¸æ£¬Ôٴξ¯¸æ£¬Ç뾡¿ì¸ü¸Ä£¬·ñÔò½ûÑÔ´¦Àí¡£ 2010-10-15 17:10:08
gdqabc(½ð±Ò+1):»¶Ó­ÌÖÂÛ 2010-10-24 08:51:35
Ã²ËÆºÍ ºË´Å¹²Õñ ÓйذÉ

רҵ¹úÍâ¶ÔÕÕÆ·²É¹º£¬ÈçÓÐÒâÏòÇëµÇ¼http://www.unitedyuyu.com/doc/pro0.htm»òÕßÖ±½ÓµçÓÊÁªÏµunitedyuyu@foxmail.com£¬µç»°0755-82282037ÉîÛÚÊÐÁªºÏÓÅÓÑ...
6Â¥2010-10-15 17:08:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

leonumn

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

gdqabc(½ð±Ò+1):»¶Ó­ÌÖÂÛ 2010-10-24 08:51:47
5. Peptide-based drugs as protease inhibitors
5.1. The Pharmacia and Upjohn inhibitor: PNU-75875
5.2. The Roche inhibitor Ro 31-8959 (saquinavir)
5.3. The Abbott compound: ritonavir (Norvir)
5.4. Merck L-735,524: indinavir
7Â¥2010-10-22 09:43:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

leonumn

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

gdqabc(½ð±Ò+1):»¶Ó­ÌÖÂÛ 2010-10-24 08:51:53
8Â¥2010-10-22 09:46:22
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

leonumn

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

gdqabc(½ð±Ò+1):»¶Ó­ÌÖÂÛ 2010-10-24 08:52:02
Activated Sulfonamides are Cleaved by Glutathione-S-Transferases
Kenneth A. Koeplinger1, Zhiyang Zhao1,2, Tillie Peterson1, Joseph W. Leone1, Francis S. Schwende2, Robert L. Heinrikson1 and Alfredo G. Tomasselli1
+ Author Affiliations

1Protein Science (K.A.K., T.P., J.W.L., R.L.H., A.G.T.) and2Drug Metabolism (Z.Z., F.S.S.), Pharmacia & Upjohn, Incorporated, Kalamazoo, Michigan
Next SectionAbstract
In preclinical pharmacokinetic studies and in in vitro rat, dog, and human primary hepatocyte incubations, the sulfonamide (-NH-SO2-) bond of a potent inhibitor of the HIV-1 protease containing the p-cyanopyridinyl moiety (PNU-109112), undergoes metabolic cleavage to form the corresponding amine metabolite (PNU-143070). Strikingly, a compound, PNU-140690, obtained by substituting the cyanopyridinyl group of PNU-109112 with a trifluoropyridinyl moiety, was stable under the same in vivo and in vitro conditions used for PNU-109112. The apparent ¡°sulfonamidase activity¡± present in liver was localized to the cytosolic fraction and shown to be an enzyme-mediated reaction requiring reduced glutathione (GSH). The enzyme responsible was purified in a single step on a GSH immobilized gel and was identified as glutathione-S-transferase (GST) by sequence analysis of peptides obtained by tryptic digestion of the purified protein. Moreover, a mixture of GST isoenzymes purified from rat liver, and three recombinant human GST isoforms, A1¨C1, M1¨C1, and P1¨C1, were active toward PNU-109112 sulfonamide cleavage; the three isoforms exhibited differential rates of PNU-109112 cleavage, demonstrating isoenzyme selectivity.
9Â¥2010-10-22 09:46:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

leonumn

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

gdqabc(½ð±Ò+1):»¶Ó­ÌÖÂÛ 2010-10-24 08:52:08
Targeting the HIV-protease in AIDS therapy: a current clinical perspective1




References and further reading may be available for this article. To view references and further reading you must purchase this article.


Alfredo G. Tomasselli and Robert L. Heinrikson2

Department of Protein Science, Pharmacia and Upjohn, Kalamazoo, MI 49001, USA

Received 1 November 1999; accepted 1 December 1999. Available online 8 March 2000.

Abstract
This review deals with clinical applications of compounds that inhibit the action of the protease encoded within the genome of human immunodeficiency virus (HIV). The HIV-protease is essential for viral maturation and represents an important therapeutic target in the fight against AIDS. Following a brief overview of the enzyme structure and function, the article focuses on a number of peptide and non-peptide based HIV-protease inhibitors that are in current clinical use. These drugs are discussed both with respect to their efficacy in treatment of AIDS, and to problems related to insurgence of viral resistance and side effects seen to date in patient populations.
10Â¥2010-10-22 09:47:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ gdqabc µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] ͶƱ:  ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿ +15 °®¿´ÊéµÄ¿ÉÀÖ 2026-08-26 17/850 2026-08-28 00:15 by xxniao123
[»ù½ðÉêÇë] ÄÄλ¸ßÈËÖÐÁË£¬°Ñ²éѯµ½µÄ½ØÍ¼Ìù³öÀ´ÈÃÎÒ¿´¿´£¬ÈÃÎÒ³¤³¤¼ûʶ +5 yuleib84 2026-08-26 6/300 2026-08-28 00:02 by yudaoqian88
[»ù½ðÉêÇë] Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ +8 Kittylucky 2026-08-27 8/400 2026-08-27 18:33 by raiy123
[½Ìʦ֮¼Ò] µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡ +7 ËÕ¶«ÆÂ¶þÊÀ 2026-08-23 7/350 2026-08-27 18:14 by ˲ϢÓîÖæ
[»ù½ðÉêÇë] »ù½ðδÖУ¬ÕâÖÖ´ð¸´ÊÇÄ£°åÂ𣿠+5 zhaosm1982 2026-08-27 6/300 2026-08-27 16:00 by lfy8008
[»ù½ðÉêÇë] ¿´°åÉÏÕâô¶àÖеģ¬ÓеãÏñ50ÈËȺÀï49¸öÈ˶¼ÊÇÆ­×ÓµÄÄÇÖָоõ¡­¡­ +5 a089 2026-08-26 6/300 2026-08-27 14:05 by jonewore
[»ù½ðÉêÇë] Ϊʲô ¹ú¼Ê(µØÇø)ºÏ×÷Óë½»Á÷ÏîÄ¿ ûÓзŰñ£¿ 10+3 majunge000 2026-08-26 11/550 2026-08-27 08:42 by ±±¾©À³Òð±à¼­
[½Ìʦ֮¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 LIbGuocjEEYw 2026-08-26 4/200 2026-08-27 04:33 by Ie9AyIAvGbvs
[»ù½ðÉêÇë] 2026ÄêµÄ¹ú¼ÒÉç¿Æ»ù½ðÏîĿͨѶÆÀÉóµÄйæÔòÓëж¯Ïò¡¢ÐÂÌôÕ½ +7 process2012 2026-08-23 10/500 2026-08-26 19:23 by hmhminy
[»ù½ðÉêÇë] ϵͳ²é²»µ½ +10 ¶­°Ëǧ 2026-08-26 10/500 2026-08-26 16:30 by Equinoxhua
[»ù½ðÉêÇë] 2026Äê8ÔÂ25ÈÕ¹ú×ÔÈ»·Å°ñǰͻȻÊÕµ½ÁÐÈëÆÀÉóר¼ÒÓʼþ£¬ÓйØÏµÂ𣿠+25 ľˮ˼¶¹ 2026-08-25 28/1400 2026-08-26 14:53 by draco1987
[»ù½ðÉêÇë] Ϊʲô¹ú×ÔÈ»²»ÄÜÖ±½Ó¹«²¼ +4 bjdxyxy 2026-08-26 4/200 2026-08-26 13:12 by qingmu1201
[»ù½ðÉêÇë] ϵͳ½ø²»È¥ +4 yanglien 2026-08-26 5/250 2026-08-26 11:10 by wenfengw83
[»ù½ðÉêÇë] ¹úºÏ¿É²éÁË +3 paperzjh 2026-08-26 3/150 2026-08-26 10:41 by LemmonTr
[Ö°³¡ÈËÉú] ѧÉúײ¼û¸¨µ¼Ô±ËÍÍâÂô£¬µÚ¶þÌìÈ«°à¶¼³ÁĬÁË +3 ¾¨ÓãÈÚ½ð_Õã½­_É 2026-08-22 3/150 2026-08-26 09:01 by zzuzxg
[»ù½ðÉêÇë] Å£À´£¡Ã×À´£¡ÃæÀ´£¡ +8 beefly 2026-08-26 8/400 2026-08-26 08:37 by xuzhipiao
[»ù½ðÉêÇë] ÔÚ¼á±ù»¹¸Ç×ű±º£µÄʱºò£¬ÎÒ¿´µ½ÁËÅ­·ÅµÄ÷»¨¡£ (½ð±Ò+10) +6 ziyangfang 2026-08-25 9/450 2026-08-25 20:26 by huagongfeihu
[»ù½ðÉêÇë] Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡· +8 scalable 2026-08-24 8/400 2026-08-25 12:52 by jnhyjjm
[»ù½ðÉêÇë] ÈËÆø²»ÐÐÁË +11 fansofjerry 2026-08-21 11/550 2026-08-25 11:04 by ¹Â¶ÀµÄÓ¢ÐÛ6
[½Ìʦ֮¼Ò] Ìø²ÛºóÔÚÑÐÏîÄ¿Ôõô°ì£¿ +5 ¼òµ¥»¯xn 2026-08-22 10/500 2026-08-23 12:38 by ¼òµ¥»¯xn
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û